First Light Asset Management »

Spyglass Pharma shares owned by First Light Asset Management

Quarter-by-quarter ownership of Spyglass Pharma shares owned by First Light Asset Management from 13F filings

Historical chart of First Light Asset Management investment in Spyglass Pharma

Tip: Access up to 7 years of quarterly data

All positions including Spyglass Pharma held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spyglass Pharma by First Light Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.7M 375k 25.91

More positions owned by First Light Asset Management

Axogen Common Stocks (AXGN)
Palvella Therapeutics Common Stocks (PVLA)
Neogenomics Common Stocks (NEO)
Si-bone Common Stocks (SIBN)
Centessa Pharmaceuticals Common Stocks (CNTA)
Apogee Therapeutics Common Stocks (APGE)
Amylyx Pharmaceuticals Common Stocks (AMLX)
Twist Bioscience Corporation Common Stocks (TWST)
Crinetics Pharmaceuticals Common Stocks (CRNX)
908 Devices Common Stocks (MASS)
Neuropace Common Stocks (NPCE)
Edgewise Therapeutics Common Stocks (EWTX)
Anaptys Bio Common Stocks (ANAB)
Simulations Plus Common Stocks (SLP)
Guardant Health Common Stocks (GH)

View all positions for First Light Asset Management

Top funds holding Spyglass Pharma

RA Capital Management
NEA Management Company
Sands Capital Ventures
Samsara BioCapital
Vestal Point Capital
Deerfield Management Company
Millennium Management
Vanguard Capital Management
First Light Asset Management
Franklin Resources
Standard Life Aberdeen
BlackRock
Geode Capital Management
Monashee Investment Management
Vanguard Fiduciary Trust

View all funds holding Spyglass Pharma